Delayed presentation of head and neck cancer patients during COVID-19 pandemic
- PMID: 33674926
- PMCID: PMC7935695
- DOI: 10.1007/s00405-021-06728-2
Delayed presentation of head and neck cancer patients during COVID-19 pandemic
Abstract
Purpose: Impact of COVID-19 pandemic on healthcare is huge. We intended to demonstrate how COVID-19 pandemic affected primary head and neck oncology patient's referral and admission to a tertiary center by comparing the retrospective patient data in March-September 2020 and the same period in 2019.
Methods: In this cross-sectional study, from March 15th, 2020 to September 15th, 2020, medical records of 61 patients (Group 1) diagnosed and scheduled for surgery for head and neck cancer in our tertiary care center were revised and compared with 64 head and neck cancer patients treated in the same institution in the same time period of the previous year (Group2). Surgical site, TNM stages, need for reconstruction with flap, time from first symptom occurrence to first admission to our institution, and time to surgery were noted.
Results: In Group 1, out of 56 patients, 26 were diagnosed with T1-2 tumor, while 30 had T3-4 tumor. In Group 2, 43 of 60 patients had T1-2 tumor, while only 17 of them were diagnosed with T3-4 tumor. The rate of T3-4 tumors had significantly increased in 2020 when compared to 2019 (p = 0.049). In oral cavity cancer patients, N stage was significantly increased in Group 1 when compared to Group 2 (p = 0.024). Need for reconstruction with regional or free flaps were significantly increased in oral cavity cancer patients (p = 0,022). The mean time from the beginning of the first symptom to the admission was 19.01 ± 4.6 weeks (ranging between 11 and 32 weeks) in Group 1, while it was 16.6 ± 5.9 weeks in Group 2 (ranging between 6 and18 weeks); with significant increase (p = 0,02). The time to surgery from first admission was 3.4 ± 2.5 and 2.9 ± 1.2 weeks in Group 1 and 2, respectively, with no statistically significant difference (p = 0.06).
Conclusion: The COVID-19 pandemic has caused delay in the diagnosis and treatment of many diseases as such in head and neck cancers. Admission with advanced stage disease and the need for more complex reconstructive procedures were increased. During the pandemic, the management of other diseases that cause mortality and morbidity should not be neglected and priorities should be determined.
Keywords: COVID-19; Delay; Head and neck cancers; Otolaryngology.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
THE IMPACT OF COVID-19 ON HEAD AND NECK CANCER TREATMENT DELAY.Acta Clin Croat. 2022 Oct;61(Suppl 4):19-25. doi: 10.20471/acc.2022.61.s4.2. Acta Clin Croat. 2022. PMID: 37250665 Free PMC article.
-
Changing trend in the management of head neck cancers during the COVID-19 pandemic.Eur Arch Otorhinolaryngol. 2022 Mar;279(3):1453-1460. doi: 10.1007/s00405-021-06898-z. Epub 2021 Jun 13. Eur Arch Otorhinolaryngol. 2022. PMID: 34120204 Free PMC article.
-
The stage of head and neck diagnosed malignancies in COVID-19 outbreak versus before outbreak: A retrospective study.Cancer Rep (Hoboken). 2023 May;6(5):e1801. doi: 10.1002/cnr2.1801. Epub 2023 Mar 16. Cancer Rep (Hoboken). 2023. PMID: 36924074 Free PMC article.
-
Effects of COVID-19 Pandemic on Otolaryngology Surgery in Italy: The Experience of Our University Hospital.Otolaryngol Head Neck Surg. 2020 Jul;163(1):86-88. doi: 10.1177/0194599820928970. Epub 2020 May 19. Otolaryngol Head Neck Surg. 2020. PMID: 32423298 Review.
-
Resurgence of regional flaps for head and neck reconstruction.Curr Opin Otolaryngol Head Neck Surg. 2021 Aug 1;29(4):237-243. doi: 10.1097/MOO.0000000000000725. Curr Opin Otolaryngol Head Neck Surg. 2021. PMID: 34109945 Review.
Cited by
-
Increasing stage and depth of invasion (DOI) in patients with tongue cancer during the COVID-19 pandemic: A time series study.Health Sci Rep. 2024 Jan 22;7(1):e1832. doi: 10.1002/hsr2.1832. eCollection 2024 Jan. Health Sci Rep. 2024. PMID: 38264159 Free PMC article.
-
[Impact of the COVID-19 pandemic on the diagnosis and treatment of patients with head and neck cancer in Brandenburg and Berlin].HNO. 2024 Feb;72(2):90-101. doi: 10.1007/s00106-023-01396-6. Epub 2023 Dec 20. HNO. 2024. PMID: 38117331 German.
-
COVID-19 impact on the management of head and neck cancer: a French single-centre experience.Eur Arch Otorhinolaryngol. 2024 Feb;281(2):873-882. doi: 10.1007/s00405-023-08245-w. Epub 2023 Oct 16. Eur Arch Otorhinolaryngol. 2024. PMID: 37845381
-
Stage shift and relative survival for head and neck cancer during the 2020 COVID-19 pandemic: a population-based study of temporal trends.Front Oncol. 2023 Sep 20;13:1253968. doi: 10.3389/fonc.2023.1253968. eCollection 2023. Front Oncol. 2023. PMID: 37799467 Free PMC article.
-
The Impact of the COVID-19 Pandemic on Urgent Awake Tracheotomies in Adults.Cureus. 2023 Aug 24;15(8):e44015. doi: 10.7759/cureus.44015. eCollection 2023 Aug. Cureus. 2023. PMID: 37753000 Free PMC article.
References
-
- H. Mehanna et al., Recommendations for head and neck surgical oncology practice in a setting of acute severe resource constraint during the COVID-19 pandemic: an international consensus. Lancet Oncol, vol. 21, no. 7. Lancet Publishing Group, pp. e350–e359, 01-Jul-2020, 10.1016/S1470-2045(20)30334-X. - PMC - PubMed
-
- H. W. Schutte et al., Impact of Time to Diagnosis and Treatment in Head and Neck Cancer: A Systematic Review. Otolaryngology Head Neck Surgery (United States), vol. 162, no. 4. SAGE Publications Inc., pp. 446–457, Apr-2020, 10.1177/0194599820906387. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
